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ABSTRACT Multiple breath wash-out (MBW) testing requires prior wash-in of inert tracer gas. Wash-in
efficiency can be enhanced by a rebreathing tracer in a closed circuit. Previous attempts to deploy this did
not account for the impact of CO2 accumulation on patients and were unsuccessful. We hypothesised that
an effective rebreathe wash-in could be delivered and it would not alter wash-out parameters.
Computer modelling was used to assess the impact of the rebreathe method on wash-in efficiency.
Clinical testing of open and closed circuit wash-in–wash-out was performed in healthy controls and adult
patients with cystic fibrosis (CF) using a circuit with an effective CO2 scrubber and a refined wash-in
protocol.
Wash-in efficiency was enhanced by rebreathing. There was no difference in mean lung clearance index
between the two wash-in methods for controls (6.5 versus 6.4; p=0.2, n=12) or patients with CF (10.9
versus 10.8; p=0.2, n=19). Test time was reduced by rebreathe wash-in (156 versus 230 s for CF patients,
p<0.001) and both methods were well tolerated. End wash-in CO2 was maintained below 2% in most
cases.
Rebreathe–wash-in is a promising development that, when correctly deployed, reduces wash-in time and
facilitates portable MBW testing. For mild CF, wash-out outcomes are equivalent to an open circuit.
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Introduction
Multiple-breath inert gas wash-out (MBW) is a sensitive and valuable research tool in the assessment of
patients with cystic fibrosis (CF) and mild airflow obstruction [1, 2]. The MBW outcome measure lung
clearance index (LCI) is more sensitive than conventional spirometry [3–5], correlates better with findings
on computed tomography [6] and is sensitive to the beneficial effects of new therapies [7, 8]. A number of
different systems are now marketed to measure LCI that comply to varying degrees with technology
recommendations [9]. Success in research studies, however, has so far not been transferred into widespread
adoption of routine MBW. MBW tests involve both a wash-in of inert tracer gas and a wash-out phase,
regardless of whether nitrogen or exogenous tracer gas washout is used, and assessment can thus take in
excess of 30 min [10]. Furthermore, both wash-out methodologies require fixed supplies of either 100%
oxygen (to wash nitrogen out) or an SF6/air mix (to wash this tracer gas in). This places restrictions on the
portability of the apparatus and limits applications to secondary care.
Efficiency of wash-in can be improved by using a rebreathe technique in a closed circuit. This involves
breathing in and out of a sealed bag filled with air supplemented with oxygen and an inert tracer gas
(e.g. SF6). Rebreathe wash-in is more rapid than open circuit, since a higher concentration of tracer is
taken into the lungs at the start of the test, and the final concentration is an equilibration of that between
the bag and the lungs (figure 1). A further advantage is that large gas cylinders providing continuous high
flows of tracer are not required. In the Innocor device (Innovision ApS, Odense, Denmark), a small
on-board cylinder is used to prime the rebreathe bag, improving the portability of the system. The only
prior report of this method used an early Innocor prototype that provided no method for removing CO2
from the circuit [11]. The build-up of CO2 within the rebreathe bag inevitably led to variable breathing
patterns, and the researchers reported low success rates and high variability in functional residual capacity
(FRC). Adding a scrubber to remove CO2 is a simple solution that has now allowed a more thorough and
detailed examination of the rebreathe methodology.
We hypothesised that the closed circuit technique could be improved so that an effective wash-in could be
achieved. We first investigated this using a computer lung model to explore the effect of ventilation
heterogeneity on lung wash-in progression. We then investigated this clinically, comparing open to closed
circuit wash-in in a group of healthy controls and patients with SF6. The specific aims of this study were:
1) to explore how ventilation heterogeneity and wash-in methodology affect efficiency of wash-in using a
two-compartment computer lung model; 2) to compare the washout parameters LCI and FRC in healthy
adult controls and patients with CF, following open and closed circuit wash-in; 3) to compare the time
taken to complete open and closed circuit wash-in; and 4) to compare patient experience of open and
closed circuit wash-in.
Materials and methods
Wash-in modelling
A two-compartment computer lung model was prepared in Matlab (Mathworks Inc., Natick, MA, USA) to
investigate the effect of wash-in protocol and ventilation heterogeneity on wash-in progression. Details are
given in the supplementary material. In brief, it allowed control of lung, rebreathe bag and breath volumes,
as well as the two major factors that influence washout progression: ventilation heterogeneity and
deadspace (both common and lung compartment specific). This was compared to a conventional open
circuit wash-in and to a modified rebreathe protocol designed to improve wash-in efficiency, which
FIGURE 1 Comparison of SF6
wash-in performed using an open
and closed circuit from the same
healthy control (aligned to display
wash-in start together). Rebreathe
wash-in included six deep breaths
at start of wash-in. This produced a
spike of SF6 followed by more rapid
equilibration of inspired and expired
concentrations. Removal of CO2
results in a persistent small
discrepancy between inspired and
expired SF6, so wash-in was
continued until this has been stable
for >30 s.
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
SF
6 
%
Time s
Closed circuit wash-in
Open circuit wash-in
0 20 40 60 80 100 120 140 160 180 200 220
ERJ Open Res 2015; 1: 00042-2015 | DOI: 10.1183/23120541.00042-2015 2
LUNG CLEARANCE INDEX | A.R. HORSLEY ET AL.
included six deep breaths at the start of wash-in. The following scenarios were then explored for all three
wash-in protocols: 1) increasing specific ventilation heterogeneity to two equal volume lung
compartments; and 2) increasingly unequal volume of the two lung compartments. As in clinical testing,
apparent incompleteness was defined as the percentage difference between inspired and expired [SF6]. The
model also allowed measurement of the true incompleteness of wash-in, here defined as the difference in
[SF6] between the two lung compartments, expressed as a percentage of the mixed expired [SF6].
Subjects
Patients with CF were recruited from two UK adult CF centres. All patients had a confirmed diagnosis of
CF and best forced expiratory volume in 1 s (FEV1) in the last 6 months of ⩾50% predicted. For infection
control purposes, patients also had to be free of infection with methicillin-resistant Staphylococcus aureus,
Burkholderia cepacia complex and Mycobacterium abscessus. All participants were nonsmokers aged
>17 years. Subjects provided signed informed consent. This study was reviewed by the Lancaster Research
Ethics Committee (ref. 13/NW/0248).
Participants underwent sequential LCI assessments using the different wash-in protocols. Wash-in
methodologies were grouped (i.e. triplicate open circuit followed by triplicate closed circuit, or vice versa).
Technical constraints meant that the open circuit method was usually performed first, followed by a rest of
⩾5 min. Spirometry was performed after MBW assessments, according to European Respiratory Society/
American Thoracic Society standards [12]. Normative values for spirometry are those provided by the
Global Lung Function Initiative [13].
Wash-out apparatus
Multiple breath wash-in and wash-out were performed using an Innocor MBW apparatus, which has been
approved by the US Food and Drug Administraiton for this purpose. Open circuit wash-in was as
previously described [3], using 0.2% SF6 in air (BOC, Guildford, UK). The closed circuit consisted of a
sealed 3-L bag filled with a mixture of room air and test gas (94% O2, 1% SF6 and 5% N2O). Switching
between air and bag was controlled by fast-operating pneumatic valves triggered at the end of expiration,
under the control of the operator (figure 2). Subjects performed wash-outs through the same patient
interface, regardless of wash-in protocol. A CO2 scrubber was placed in sequence between the bag and
patient, so that expired air was depleted of CO2 prior to re-inspiration.
Based on the modelling data, a modified wash-in protocol was used in order to achieve a more efficient
wash-in. This consisted of three novel components: 1) a double CO2 scrubber; 2) an increase in the
fraction of the bag volume filled with test gas to 40%, which increases inspired [O2] at the start of wash-in
and extends wash-in time before this falls below 20%; and 3) six deep breaths at the start of wash-in,
which increases total cumulative inspired volume as well as ensuring poorly ventilated compartments are
reached at the start, when the inspired SF6 fraction is high. Wash-in was continued until the SF6 signal had
been stable for >30 s. Removal of CO2 results in a persistent small discrepancy between inspired and expired
SF6, so this was not always an entirely flat line, in which case the difference was required to be stable.
Six subjects underwent additional open circuit wash-in using a gas mix that included 2% CO2. The details
of these experiments are included in the supplementary material.
FIGURE 2 Diagram of rebreathe
apparatus. The patient breathes
through a filter and flow meter into
a T-piece with two valve-controlled
exits: one to room air and one to
the rebreathe bag. This is filled
with a mixture of air and test gas,
and is enriched with O2 from the
test gas. A CO2 scrubber placed in
series removes CO2 from expired
air. The patient breathes either
from the rebreathe bag with the air
valve closed (wash-in) or breathes
room air with the bag valve closed
(wash-out).
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Analysis
Analysis of wash-in and wash-out was performed offline using software prepared in Igor Pro v6
(Wavemetrics Inc., Lake Oswego, OR, USA) as previously described [10]. “Incompleteness” of wash-in was
defined as the difference between inspired and expired SF6 concentrations, expressed as a percentage of the
inspired SF6. During rebreathe wash-in, adjustment was made for the effects of CO2 removal on the
concentration of SF6. LCI and FRC were calculated according to recent guidelines, including adjustment
for re-inspired SF6, and pre- and post-capillary deadspaces (48 and 12 mL, respectively, for this adult
MBW configuration) [9].
Patient feedback
At the end of wash-out testing, participants were asked to complete a questionnaire on their experience of
the two methods. This contained free text responses and visual analogue scores (VASs) to rate the
experience, using a questionnaire designed for this study and based on those used in previous studies [14].
VASs were expressed as a percentage of a maximum score of 100.
Statistics
Data were analysed using Prism (GraphPad Software Inc., San Diego, CA, USA). Normal distribution was
assessed using the D’Agostino and Pearson omnibus normality test. Data are presented as mean±SD or
median (interquartile range (IQR)) unless otherwise stated. Fisher’s exact test was used to compare
proportions. Bland–Altman analysis was used to compare LCI and FRC generated from different wash-in
methods, and paired t-tests used to describe the significance of the difference between methods.
Repeatability of tests was expressed as the coefficient of variation (CoV) from wash-out repeats performed
during a single sitting. A p-value <0.05 was considered to be statistically significant.
Results
Wash-in modelling
Full wash-in profiles across the different scenarios are presented in the supplementary material. A
representative profile is shown in figure 3 for the different wash-in protocols in a case of moderately severe
ventilation heterogeneity (first lung compartment volume 0.7, fractional ventilation 0.3, model LCI 10).
In both ventilation heterogeneity scenarios, a similar picture was observed: wash-in was prolonged by
increasing ventilation or volume heterogeneity but was more efficient with the closed circuit method.
Adding deep breaths at the start of wash-in deep led to a much more effective and rapid wash-in.
Apparent incompleteness, however, fell much faster in a closed circuit, particularly if deep breaths were
employed at the start of wash-in, than the true difference in SF6 between compartments.
Clinical testing
LCI from open circuit wash-in and modified rebreathe wash-in was compared in 31 subjects: 19 patients
with CF patients and 12 healthy controls. Demographic and lung function data are presented in table 1.
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FIGURE 3 Effect of ventilation heterogeneity on wash-in progress. Wash-ins are all from a model with a first lung compartment volume (V1) of 0.7
and fractional ventilation 0.3 (giving a model lung clearance index of 10). Three different wash-in scenarios are presented: open circuit, closed
circuit with tidal breaths and closed circuit with six deep breaths at the start of wash-in. a) Wash-in progression, as shown by expired end-tidal
SF6. Target end tidal SF6 (representing complete gas equilibrium throughout the model) is shown as a horizontal dotted line. Closed circuit wash-
in to 0.1% SF6 and open circuit wash-in to 0.2% SF6 are shown to same scale on the different axes. b) Apparent wash-in incompleteness
(measured as difference between inspired and expired SF6 concentrations at the mouth). c) True wash-in incompleteness, expressed as the
percentage difference between SF6 concentrations in the two compartments.
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CF patients had lower spirometric parameters than controls and higher LCI. Neither FRC nor LCI were
significantly different between open wash-in and rebreathe wash-in. Bland–Altman plots of these data are
shown in figures 4 and 5, respectively. For LCI, there were similar 95% limits of agreement (LOA) between
the two methods to those previously been described for healthy subjects on different visits using open
circuit wash-in (bias 0.1, LOA −0.4–0.6) [3]. For CF patients, the variability between the two wash-in
methods was greater but was similar below an LCI of 13 (overall bias 0.2, LOA −1.0–1.3). A single subject
had very much greater LCI from open versus closed circuit wash-in (15.6 versus 13.9) but he also had
unstable wash-out measurements by both methods (CoV FRC 9%, CoV LCI 7%). Removing this outlier
reduces the LOA by 18%.
There was a reduction in wash-in time by 50% (controls) and 32% (CF patients) using the rebreathe
method (table 2). Median (IQR) end wash-in O2 concentration was 23.1% (19.0–26.4%) for CF patients.
End wash-in inspired CO2 was <2% in all but one CF patient, and median end wash-in CO2 was not
significantly different between CF and controls (1.3 versus 1.4%, p=0.5). This does not appear to have had
a significant effect on washout breathing patterns: mean±SD wash-out tidal volume (VT) and respiratory
rate were no different between open and closed wash-in (847±168 versus 883±186 mL (p=0.09) and 14±4
versus 13±4 breaths per min (p=0.06)).
Repeatability
There were no statistically significant differences in repeatability for LCI or FRC, as measured by the CoV
of repeat assessments performed at the same sitting. For CF patients, median (IQR) CoV for LCI was 2.1%
(0.9–3.6%) for open circuit wash-in versus 3.2% (0.9–6.4%) for closed circuit (p=0.5). For FRC, the CoV of
repeat measurements was 3.5% (1.5–7.3%) for open circuit wash-in versus 4.8% (1.8–6.7%) for closed
circuit (p>0.9).
Patient experience
Questionnaires were collected from 24 participants, comprising 11 controls and 13 CF patients (table 3).
All wash-in protocols were generally well tolerated. There were no significant differences in VAS scores
between open and closed methods or between CF patients and controls for any parameters. The most
common comment about the tests in general (from 20 (83%) respondents) were that they were “fine”,
“okay”, “comfortable” or that the participant had “no problems”. When asked to indicate the worst part of
the test, the most common complaint was discomfort due to the nose clip in 10 (42%) respondents.
TABLE 1 Summary demographic and washout data for control and cystic fibrosis subjects who
completed repeat wash-out measurements with both an open circuit wash-in and a modified
closed circuit wash-in
Healthy
volunteers
Cystic
fibrosis
p-value for healthy volunteers versus
cystic fibrosis
Subjects n 12 19
Age years 34.2±10.4 30.2±6.2 0.2
Males/females n/n 1/11 13/6 0.002
FEV1 z-score −0.5±1.0 −2.3±1.3 0.0006
FVC z-score −0.1±1.2 −1.2±1.2 0.03
FEV1 % predicted −94.7±12.5 71.9±15.9 0.0005
FEV1/FVC 0.80±0.07 0.69±0.09 0.003
LCI open 6.5±0.5 10.9±2.6 <0.0001
LCI closed 6.4±0.5 10.8±2.2 <0.0001
p-value for open versus
closed
0.2 0.2
FRC open L 2.32±0.70 2.66±0.81 0.2
FRC closed L 2.34±0.67 2.75±0.80 0.2
p-value for open versus
closed
0.6 0.1
Data are presented as mean±SD unless otherwise stated. FEV1: forced expiratory volume in 1 s; FVC:
forced vital capacity; LCI: lung clearance index; FRC: functional residual capacity.
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Discussion
This is the first study to systematically compare open and closed circuit wash-in methods using a closed
circuit technique that includes an effective CO2 scrubber. We have shown that closed circuit wash-in is a
simple and more rapid technique for equilibrating tracer gas into the lungs prior to a MBW. We have also
shown that wash-in efficiency is enhanced by deep breaths at the start of wash-in and that this is
necessary in order to achieve rapid wash-in in CF patients with ventilation heterogeneity. CO2 and O2 can
be maintained in the rebreathe bag at levels that are safe and acceptable to patients. For patients with mild
to moderate CF (FEV1 >50% predicted), this method did not result in systematic change in FRC, LCI or
wash-out breathing patterns. When ventilation heterogeneity is severe, in other words, LCI is very high,
the rebreathe wash-in described here may not achieve as effective wash-in as a much more prolonged open
circuit wash-in. A possible effect of this is may be a lower LCI when LCI is above the mid-teens.
In order to aid interpretation of the clinical observations, we have developed a lung model to investigate
wash-in progress in the context of ventilation heterogeneity. The model allows control of both deadspace
and specific ventilation, and permits us to follow the tracer gas signal at the mouth and within the lung
compartments. The results reveal that apparently complete wash-in can hide more significant differences
between lung compartments. This is particularly the case with rebreathe wash-in, where although <2%
difference between inspired and expired SF6 concentration can be very rapidly achieved, this end-point is
reached before adequate wash-in of less well ventilated lung compartments has occurred.
As a result of these observations, we have amended the wash-in method to incorporate deep inspirations at
the start and to permit a more prolonged closed circuit wash-in. Wash-in can now be comfortably continued
for 3 min without [CO2] rising above 2% or [O2] falling below that in room air. We have also shown that
CO2 at this level does not appear to affect the LCI. This delivers two major advantages for the rebreathe
method. Even though time savings overall may be modest (since wash-out time is unaffected), these are
important in the context of clinical deployment, where test time is a major barrier to uptake. Unlike N2
wash-out, there is also no need to wait before starting the next wash-in, and the three tests follow after each
other in rapid succession. In a recent attempt to introduce LCI measurements into a clinic setting, SINGER
et al. [15] restricted themselves to a 20-min time window. In MBW-naïve children, they were unable to
complete more than a single N2 wash-out assessment in 59% of subjects, which is insufficient for accurate
reporting of LCI [9]. In response to this, attempts have been made to truncate the wash-out, ending at an
earlier point [10, 16]. The results have been disappointing, however, with modest time saved offset by a
negative impact on sensitivity. With a correctly performed rebreathe wash-in, however, the time saving is at
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least as great and the signal component of the LCI is preserved. Since the objective of this study was to
compare closed circuit to conventional MBW, we have not assessed the impact of deep breathing on open
circuit wash-in. It is likely that this would also serve to reduce wash-in time. However, the other major
advantage of rebreathe wash-in is that the MBW apparatus is rendered genuinely portable and has since been
mounted on a medical cart with an on-board power supply for bedside MBW measurements.
It is important to consider why the experience of closed circuit MBW here was so substantially different to
that reported by PITTMAN et al. [11]. Their study used an early prototype Innocor-rebreathe, without a CO2
scrubber and with automated wash-in algorithms that had not been tested in clinical practice. It is clear that
their subjects found rebreathing uncomfortable, resulting in a tendency to take deeper breaths that was
restricted by the low filling volume of the bag (1.5VT). This early failure of the closed circuit method led to
a recommendation against the technique [1]. In many regards, the experience of PITTMAN et al. [11] mirrors
our own early observations when such protocols were attempted. In order to overcome this, we have
deployed an effective CO2 scrubber that limits accumulation of CO2 to typically <2%. We use inspiratory
volume feedback to help patients maintain a regular VT throughout the latter part of wash-in and wash-out.
However, we also fill the bag to a volume of at least ⩾3VT (range 2–3 L), which accommodates deeper
breaths and ensures that inspired O2 remains >20%. Instead of an automated end of wash-in algorithm, we
use manual control of wash-in termination, based upon recognition of stable expired SF6 signals for ⩾30 s.
Finally, the measurement of FRC reported here was obtained from wash-out, as per open circuit methods,
and in contrast to the earlier report. In this study, patient experience of both open and closed circuit
methods was good, with no significant differences in comfort scores between the two methods.
An inherent disadvantage of the rebreathe method is that it is may not be suitable for those with very
abnormal gas mixing and thus very high LCI. An effective wash-in may not always be achieved throughout
the lungs in this scenario within the wash-in time described here, though further developments to permit
TABLE 2 Effect of wash-in methodology on wash-in time and other parameters
Open Rebreathe p-value for open versus rebreathe
Healthy volunteers
Total wash-in time s 202 (142–229) 101 (89–142) 0.0005
Cumulative inspired volume L 19.8±4.3 17.9±5.4 0.2
Wash-in incompleteness % 1.25±0.36 0.53±0.60 0.003
Median end wash-in CO2 % 1.4 (1.0–3.5)
Cystic fibrosis
Total wash-in time s 230 (204–280)* 156 (132–173)* <0.0001
Cumulative inspired volume L 38.4±8.4# 32.2±6.2# 0.01
Wash-in incompleteness % 1.76 (0.74) 1.18 (0.82)* 0.0007
Median end wash-in CO2 % 1.3 (1.1–1.7)
Data are presented as median (interquartile range) or mean±SD, unless otherwise stated. *: p<0.05 for
healthy volunteers versus CF; #: p<0.0001 for healthy volunteers versus CF.
TABLE 3 Summary of patient feedback demographics and visual analogue score (VAS)
responses
Healthy volunteers Cystic fibrosis
Open Closed Open Closed
Subjects n 11 13
Males/females n/n 1/10 10/3
Age years 34.4±10.8 31.0±5.3
LCI 6.6 (0.5) 10.9 (2.2)
VAS score
Ease of wash-out % 93 (71–96) 85 (80–91) 93 (81–99) 87 (78–96)
Ease of wash-in % 96 (95–100) 95 (79–100) 89 (80–97) 87 (72–93)
Time taken to complete % 81 (78–97) 87 (79–97) 77 (69–95) 81 (69–95)
Data are presented as mean±SD or median (interquartile range), unless otherwise stated. LCI: lung
clearance index.
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longer wash-in may support this. In reality, however, these are not the patients in whom MBW testing
should be targeted [17]. The advantages and strengths of LCI in particular appear to be in those with mild
airways disease and rebreathe wash-in is equivalent to open circuit in these patients. In conclusion, we
have demonstrated the successful adaptation and deployment of a novel rebreathe methodology to perform
inert gas wash-in. We have also developed a lung model that considerably aids the design of improved
protocols for wash-out measurements. We have shown that rebreathe wash-in permits the use of a
portable system that reduces wastage of tracer gas and avoids potential confounding effects of body N2 on
washout parameters. Although this method cannot easily be implemented to aid the use of N2 MBW, it
can be applied to any system based on inhaled tracer gases. This is an important new development in
MBW testing that will facilitate rapid and portable measurement of LCI.
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